Literature DB >> 20438448

Design, synthesis and biological evaluation of a library of thiocarbazates and their activity as cysteine protease inhibitors.

Zhuqing Liu1, Michael C Myers, Parag P Shah, Mary Pat Beavers, Phillip A Benedetti, Scott L Diamond, Amos B Smith, Donna M Huryn.   

Abstract

Recently, we identified a novel class of potent cathepsin L inhibitors, characterized by a thiocarbazate warhead. Given the potential of these compounds to inhibit other cysteine proteases, we designed and synthesized a library of thiocarbazates containing diversity elements at three positions. Biological characterization of this library for activity against a panel of proteases indicated a significant preference for members of the papain family of cysteine proteases over serine, metallo-, and certain classes of cysteine proteases, such as caspases. Several potent inhibitors of cathepsin L and S were identified. The SAR data were employed in docking studies in an effort to understand the structural elements required for cathepsin S inhibition. This study provides the basis for the design of highly potent and selective inhibitors of the papain family of cysteine proteases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20438448      PMCID: PMC2975254          DOI: 10.2174/138620710791054303

Source DB:  PubMed          Journal:  Comb Chem High Throughput Screen        ISSN: 1386-2073            Impact factor:   1.339


  25 in total

1.  Development of peptidyl alpha-keto-beta-aldehydes as new inhibitors of cathepsin L--comparisons of potency and selectivity profiles with cathepsin B.

Authors:  J F Lynas; S J Hawthorne; B Walker
Journal:  Bioorg Med Chem Lett       Date:  2000-08-07       Impact factor: 2.823

Review 2.  Recent advances in the synthesis, design and selection of cysteine protease inhibitors.

Authors:  Alejandro Alvarez Hernandez; William R Roush
Journal:  Curr Opin Chem Biol       Date:  2002-08       Impact factor: 8.822

3.  Direct evidence for the presence of histidine in the active center of chymotrypsin.

Authors:  G SCHOELLMANN; E SHAW
Journal:  Biochemistry       Date:  1963 Mar-Apr       Impact factor: 3.162

4.  Synthesis and SAR of arylaminoethyl amides as noncovalent inhibitors of cathepsin S: P3 cyclic ethers.

Authors:  David C Tully; Hong Liu; Arnab K Chatterjee; Phil B Alper; Robert Epple; Jennifer A Williams; Michael J Roberts; David H Woodmansee; Brian T Masick; Christine Tumanut; Jun Li; Glen Spraggon; Michael Hornsby; Jonathan Chang; Tove Tuntland; Thomas Hollenbeck; Perry Gordon; Jennifer L Harris; Donald S Karanewsky
Journal:  Bioorg Med Chem Lett       Date:  2006-07-28       Impact factor: 2.823

5.  Kinetic characterization and molecular docking of a novel, potent, and selective slow-binding inhibitor of human cathepsin L.

Authors:  Parag P Shah; Michael C Myers; Mary Pat Beavers; Jeremy E Purvis; Huiyan Jing; Heather J Grieser; Elizabeth R Sharlow; Andrew D Napper; Donna M Huryn; Barry S Cooperman; Amos B Smith; Scott L Diamond
Journal:  Mol Pharmacol       Date:  2008-04-10       Impact factor: 4.436

6.  Design, synthesis, and evaluation of inhibitors of cathepsin L: Exploiting a unique thiocarbazate chemotype.

Authors:  Michael C Myers; Parag P Shah; Mary Pat Beavers; Andrew D Napper; Scott L Diamond; Amos B Smith; Donna M Huryn
Journal:  Bioorg Med Chem Lett       Date:  2008-05-01       Impact factor: 2.823

7.  The crystal structure of human cathepsin L complexed with E-64.

Authors:  A Fujishima; Y Imai; T Nomura; Y Fujisawa; Y Yamamoto; T Sugawara
Journal:  FEBS Lett       Date:  1997-04-21       Impact factor: 4.124

8.  The design of peptidyldiazomethane inhibitors to distinguish between the cysteine proteinases calpain II, cathepsin L and cathepsin B.

Authors:  C Crawford; R W Mason; P Wikstrom; E Shaw
Journal:  Biochem J       Date:  1988-08-01       Impact factor: 3.857

9.  Synthesis of (arylalkenyl)silanes by palladium-catalyzed regiospecific and stereoselective allyl transfer from silyl-substituted homoallyl alcohols to aryl halides.

Authors:  Sayuri Hayashi; Koji Hirano; Hideki Yorimitsu; Koichiro Oshima
Journal:  J Am Chem Soc       Date:  2007-09-29       Impact factor: 15.419

10.  Synthesis of peptide fluoromethyl ketones and the inhibition of human cathepsin B.

Authors:  D Rasnick
Journal:  Anal Biochem       Date:  1985-09       Impact factor: 3.365

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.